Amgen (AMGN) suffered a major setback when its phase III study, FOCUS (CarFilzOmib for AdvanCed Refractory MUltiple Myeloma European Study) on multiple myeloma treatment, Kyprolis did not meet its primary endpoint. The open-label study evaluated Kyprolis versus an active control regimen of low-dose dexamethasone, or equivalent corticosteroids, plus optional cyclophosphamide in patients suffering from relapsed…
Tesla Motors Inc (NASDAQ TSLA) customers now have yet another reason to cheer. The electric vehicle maker is gearing up to roll out the version 6.0 update to Model S software. It will allow users to unlock and start their cars with the Apple (NASDAQ AAPL) product iPhone (if they have one) just in case…
BitPay executive chairman Tony Gallippi announced today that his company paid for its upcoming college football bowl game sponsorship in bitcoin. The surprise news came at a press conference held by BitPay and the St. Petersburg Chamber of Commerce to promote the upcoming Bitcoin St. Petersburg Bowl. There, Gallippi revealed that BitPay paid ESPN Events,…
In an important news for the Facebook (NASDAQ FB) Stock, Snapchat, Inc. plans to launch its Snapchat Discovery service by November of this year. The service will enable advertising and media companies to promote their products by sharing disappearing ads, news content, videos, and articles with Snapchat users. Snapchat plans to launch Snapchat Discovery, a…
Google X is where its “outside the norm” ideas are launched. The outside of the box projects that the company hopes will make it one of the leading technology companies for the remainder of the century and beyond. Google ended the week by wrapping up the acquisition of Gecko Design which will be incorporated in…
Achillion Pharmaceuticals, Inc (ACHN) reported positive interim results from a phase II study (n=12) on its hepatitis C virus (HCV) candidate, ACH-3102. The company’s shares jumped 9.6% following the news. The mid-stage study is evaluating a ribavirin-free regimen of ACH-3102 in combination with Gilead’s (GILD) Sovaldi (sofosbuvir) for the treatment of patients suffering from treatment-naïve…
